The Evolving Landscape of Incretin Therapies: Evidence, Outcomes, and Emerging Applications

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Pharmacists

Description

Join us for an engaging pharmacy CEU webinar exploring the rapidly evolving role of incretin-based therapies in diabetes, obesity, and cardiometabolic care. This session will review the efficacy, safety, and clinical differences among currently available agents while highlighting emerging evidence supporting benefits beyond glycemic control and weight reduction, including cardiovascular and kidney outcomes. Participants will also gain insight into novel dual- and triple-agonist therapies currently shaping the future of treatment. Through guideline updates and clinical trial data, pharmacists and healthcare professionals will learn practical strategies to individualize patient selection, initiation, monitoring, and ongoing management of incretin-based therapies in clinical practice.

Continuing Education Credit For Pharmacists:
The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE #0046-9999-26-156-L01-P(Pharmacist) provides 2.0 contact hours of continuing pharmacy education credit. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks. **No partial credit will be available**

Upcoming Pharmacy Live Webinars

Pharmacy-Based Immunization Updates 2026
September 30th, 2026 | 6:00pm-9:00pm
Pulse Check: What’s New in Cardiology
October 6th, 2026 | 6:30pm-8:30pm
New Drug Update 2026: A Formulary Approach
November 3rd, 2026 | 6:30pm-8:30pm
The 29th Annual Procrastinators Marathon: Hot Topic Updates in Pharmacy
November 20th, 2026 | 8:00am-3:00pm
The Evolving Landscape of Incretin Therapies: Evidence, Outcomes, and Emerging Applications
December 2nd, 2026 | 6:30pm-8:30pm

Live Webinar Information
This webinar will be broadcast with Zoom. Instructions to join the webinar will be emailed prior to the event. Please go to our live webinar requirements page for more information and to test the computer/device and network prior to the event.

Registering for and attending a South Piedmont AHEC program authorizes South Piedmont AHEC to take audio, video, and/or still images to be used for promotional and educational purposes. If you have concerns, please speak with a South Piedmont AHEC team member.

Objectives

• Discuss the efficacy, safety, and clinical characteristics of currently available incretin-based therapies for diabetes and obesity.
• State recent cardiovascular, kidney, and metabolic outcomes data supporting incretin therapy use beyond glycemic control and weight reduction.
• Describe emerging incretin agents and novel mechanisms, including dual- and triple-agonist therapies, and their potential role in future practice.
• Explain guideline recommendations and clinical trial data to individualize patient selection, initiation, monitoring, and management of incretin-based therapy.

Sessions